Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
115.8(c) 110.8(c) 109.8(c) 111.3(c) 111.5(c) Last
94 035 192 691 169 700 99 252 98 324 Volume
-2.61% -4.32% -0.90% +1.37% +0.18% Change
More quotes
Financials
Sales 2020 1 348 M 1 613 M 1 613 M
Net income 2020 126 M 151 M 151 M
Net cash position 2020 562 M 672 M 672 M
P/E ratio 2020 74,3x
Yield 2020 0,50%
Sales 2021 1 499 M 1 793 M 1 793 M
Net income 2021 167 M 200 M 200 M
Net cash position 2021 681 M 814 M 814 M
P/E ratio 2021 57,1x
Yield 2021 0,58%
Capitalization 9 973 M 11 923 M 11 928 M
EV / Sales 2020 6,98x
EV / Sales 2021 6,20x
Nbr of Employees 3 335
Free-Float 40,9%
More Financials
Company
Carl Zeiss Meditec AG specializes in the production and marketing of ophthalmologic diagnosis systems and equipment. The group also manufactures and sells microsurgical visualization systems and ophthalmic surgery equipment. Net sales break down by family of products as follows: - ophthalmologic diagnosis systems and equipment (73.2%): slit lamps, corneal topography systems, retinal imaging systems, keratometers,... 
More about the company
Notations Surperformance© of Carl Zeiss Meditec AG
Trading Rating : Investor Rating :
More Ratings
All news about CARL ZEISS MEDITEC AG
11/16CARL ZEISS MEDITEC : ZEISS presents integrated workflow advancements at AAO
AQ
11/06CARL ZEISS MEDITEC AG : DZ Bank reaffirms its Sell rating
MD
10/30CARL ZEISS MEDITEC AG : Kepler Cheuvreux remains a Sell rating
MD
10/30CARL ZEISS MEDITEC AG : UBS reaffirms its Neutral rating
MD
10/29CARL ZEISS MEDITEC : Ad Hoc Announcement 29-Oct-2020
PU
10/29CARL ZEISS MEDITEC AG : Berenberg reiterates its Neutral rating
MD
10/29CARL ZEISS MEDITEC : concludes fiscal year 2019/20 with a recovery in profit in ..
EQ
10/23CARL ZEISS MEDITEC AG : UBS is now Neutral
MD
10/23CARL ZEISS MEDITEC AG : Hauck & Aufhauser gives a Neutral rating
MD
10/06CARL ZEISS MEDITEC AG : Hauck & Aufhauser reaffirms its Buy rating
MD
09/23CARL ZEISS MEDITEC AG : Gets a Neutral rating from Berenberg
MD
09/18CARL ZEISS MEDITEC AG : Hauck & Aufhauser reiterates its Buy rating
MD
09/11CARL ZEISS MEDITEC : ZEISS Medical Technology Nominated for Deutscher Zukunftspr..
AQ
09/07CARL ZEISS MEDITEC AG : Notification and public disclosure of transactions by pe..
EQ
09/02CARL ZEISS MEDITEC AG : From Neutral to Buy by Hauck & Aufhauser
MD
More news
News in other languages on CARL ZEISS MEDITEC AG
11/25Schott fabrique des flacons indispensables aux vaccins contre le Covid-19
11/06CARL ZEISS MEDITEC AG : DZ Bank conserve son opinion négative
11/06DZ Bank hebt fairen Wert für Carl Zeiss Meditec - 'Verkaufen'
10/30CARL ZEISS MEDITEC AG : Kepler Cheuvreux est négatif
10/30Kepler Cheuvreux belässt Carl Zeiss Meditec auf 'Reduce'
More news
Analyst Recommendations on CARL ZEISS MEDITEC AG
More recommendations
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | AFX | DE0005313704 | MarketScreener
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 102,25 €
Last Close Price 111,50 €
Spread / Highest target 30,0%
Spread / Average Target -8,30%
Spread / Lowest Target -53,4%
EPS Revisions
Managers
NameTitle
Ludwin Monz President & Chief Executive Officer
Michael Kaschke Chairman-Supervisory Board
Justus Felix Wehmer Chief Financial Officer
Markus Guthoff Member-Supervisory Board
Cornelia Grandy Member-Supervisory Board
Sector and Competitors